Yu R - Search Results

1

Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.

Song YL, Yu R, Qiao XW, Bai CM, Lu CM, Xiao Y, Zhong DR, Chen J, Zhao YP, Zhang TP, Song TT, Gao HL, Wan YH, Shen L, Chen J, Lv B, Hao JJ, Zhang Y, Tang L, Chen YJ. Song YL, et al. Among authors: yu r. Sci Rep. 2017 May 19;7(1):2205. doi: 10.1038/s41598-017-02051-1. Sci Rep. 2017. PMID: 28526880 Free PMC article.

2

Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis.

Yu R, Heaney AP, Lu W, Chen J, Melmed S. Yu R, et al. J Biol Chem. 2000 Nov 24;275(47):36502-5. doi: 10.1074/jbc.C000546200. J Biol Chem. 2000. PMID: 11013229 Free article.

3

Pancreatic neuroendocrine tumors: presentation, management, and outcomes.

Nissen NN, Kim AS, Yu R, Wolin EM, Friedman ML, Lo SK, Wachsman AM, Colquhoun SD. Nissen NN, et al. Among authors: yu r. Am Surg. 2009 Oct;75(10):1025-9. Am Surg. 2009. PMID: 19886158

4

Animal models and cell lines of pancreatic neuroendocrine tumors.

Babu V, Paul N, Yu R. Babu V, et al. Among authors: yu r. Pancreas. 2013 Aug;42(6):912-23. doi: 10.1097/MPA.0b013e31827ae993. Pancreas. 2013. PMID: 23851429 Review.

5

α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness.

Liu B, Tang LH, Liu Z, Mei M, Yu R, Dhall D, Qiao XW, Zhang TP, Zhao YP, Liu TH, Xiao Y, Chen J, Xiang HD, Wu HY, Lu CM, Lv B, Zhou YR, Zhang Y, Deng D, Chen YJ. Liu B, et al. Among authors: yu r. J Clin Endocrinol Metab. 2014 May;99(5):E786-95. doi: 10.1210/jc.2013-2874. Epub 2014 Jan 31. J Clin Endocrinol Metab. 2014. PMID: 24483152

6

Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.

Zhu LM, Tang L, Qiao XW, Wolin E, Nissen NN, Dhall D, Chen J, Shen L, Chi Y, Yuan YZ, Ben QW, Lv B, Zhou YR, Bai CM, Chen J, Song YL, Song TT, Lu CM, Yu R, Chen YJ. Zhu LM, et al. Among authors: yu r. Medicine (Baltimore). 2016 Feb;95(7):e2836. doi: 10.1097/MD.0000000000002836. Medicine (Baltimore). 2016. PMID: 26886644 Free PMC article.

7

A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series.

Yu R, Nissen NN, Hendifar A, Tang L, Song YL, Chen YJ, Fan X. Yu R, et al. Pancreas. 2017 Jan;46(1):48-56. doi: 10.1097/MPA.0000000000000718. Pancreas. 2017. PMID: 27984486

8

Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide.

Zalom ML, Waxman AD, Yu R, Lee J, Ih G, Wolin EM. Zalom ML, et al. Among authors: yu r. Endocr Pract. 2009 Sep-Oct;15(6):521-7. doi: 10.4158/EP08318.ORR1. Endocr Pract. 2009. PMID: 19491080

9

Pathogenesis of pituitary tumors.

Yu R, Melmed S. Yu R, et al. Prog Brain Res. 2010;182:207-27. doi: 10.1016/S0079-6123(10)82009-6. Prog Brain Res. 2010. PMID: 20541667

10

Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.

Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, Yu R, Nissen NN, Wolin E. Dhall D, et al. Among authors: yu r. Hum Pathol. 2012 Apr;43(4):489-95. doi: 10.1016/j.humpath.2011.06.011. Epub 2011 Sep 19. Hum Pathol. 2012. PMID: 21937080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,504 results

Search Page